Allscripts Healthcare Solutions (MDRX) Earns News Sentiment Rating of 0.14

News headlines about Allscripts Healthcare Solutions (NASDAQ:MDRX) have trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned headlines about the software maker an impact score of 46.5671286924953 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Shares of MDRX stock opened at $12.48 on Tuesday. Allscripts Healthcare Solutions has a 12 month low of $10.78 and a 12 month high of $16.13. The company has a market cap of $2.24 billion, a price-to-earnings ratio of 26.55, a price-to-earnings-growth ratio of 1.68 and a beta of 1.26. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.02 and a quick ratio of 1.02.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, May 3rd. The software maker reported $0.16 EPS for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.01). Allscripts Healthcare Solutions had a negative net margin of 11.34% and a positive return on equity of 7.80%. The business had revenue of $518.60 million for the quarter, compared to analysts’ expectations of $527.34 million. During the same period in the prior year, the company posted $0.13 earnings per share. The firm’s quarterly revenue was up 24.9% on a year-over-year basis. research analysts predict that Allscripts Healthcare Solutions will post 0.55 earnings per share for the current year.

MDRX has been the subject of several research reports. Bank of America initiated coverage on shares of Allscripts Healthcare Solutions in a report on Tuesday, February 27th. They set a “buy” rating and a $17.00 price objective for the company. Cantor Fitzgerald reissued a “buy” rating and set a $18.00 price objective on shares of Allscripts Healthcare Solutions in a report on Tuesday, March 6th. BidaskClub cut shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, March 14th. ValuEngine cut shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Tuesday, April 3rd. Finally, TheStreet cut shares of Allscripts Healthcare Solutions from a “b-” rating to a “c” rating in a report on Monday, April 2nd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $16.01.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $12.40, for a total value of $186,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael Klayko purchased 4,000 shares of the company’s stock in a transaction on Wednesday, June 13th. The stock was purchased at an average price of $12.52 per share, with a total value of $50,080.00. Following the completion of the transaction, the director now owns 117,315 shares of the company’s stock, valued at $1,468,783.80. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by corporate insiders.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with's FREE daily email newsletter.

Leave a Reply